Şunu mu demek istediniz:
"medication use" » "education use" (Aramayı Genişlet), "modification use" (Aramayı Genişlet), "medication used" (Aramayı Genişlet)
"medication use" » "education use" (Aramayı Genişlet), "modification use" (Aramayı Genişlet), "medication used" (Aramayı Genişlet)
-
1
Comparison of work productivity and QoL between women with normal and severe dysmenorrhea scores.
Baskı/Yayın Bilgisi 2025Konular: -
2
-
3
Multiple regression analyses of factors associated with work productivity and QoL.
Baskı/Yayın Bilgisi 2025Konular: -
4
Participant characteristics in the overall cohort and in groups classified by dysmenorrhea score.
Baskı/Yayın Bilgisi 2025Konular: -
5
Comparison of WPAI-GH and SF-36v2 scores between normal and severe groups classified by dysmenorrhea score.
Baskı/Yayın Bilgisi 2025Konular: -
6
-
7
-
8
Baseline Characteristics of the Study Population by Hyperlipidemia Status.
Baskı/Yayın Bilgisi 2025Konular: -
9
Mediation analysis of the association between DI-GM and Hyperlipidemia via SII.
Baskı/Yayın Bilgisi 2025Konular: -
10
Subgroup analyses of the association between DI-GM and hyperlipidemia.
Baskı/Yayın Bilgisi 2025Konular: -
11
Restricted cubic spline analysis of the relationship between DI-GM and hyperlipidemia.
Baskı/Yayın Bilgisi 2025Konular: -
12